C
CVS Health Corporation (CVS)
NYQ – Real Time Price. Currency in USD
95.15
+2.93 (3.18%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
95.15
+2.93 (3.18%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.87 | 2.52 | 5.0 | |
| Quick ratio | 0.66 | 2.36 | 4.0 | |
| Debt to Equity | 1.01 | 0.46 | 6.0 | |
| Debt to Assets | 0.31 | 0.44 | 7.0 | |
| Interest coverage | 6.08 | 67.62 | 10 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 322.79B | 358.27B | 372.69B | 402.11B | 407.94B |
| Gross Profit | 54.82B | 54.93B | 51.28B | 55.41B | 56.63B |
| Operating Income | 16.61B | 15.58B | 9.92B | 12.47B | 13.30B |
| Net Income | 4.31B | 8.34B | 4.61B | 1.77B | 2.93B |
| EBITDA | 20.83B | 19.95B | 14.52B | 17.07B | 17.86B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1.07 | 0.86 | 2.5 |
| Next quarter | 0.4 | 9.27 | 4.0 |
| Current year | 1.01 | 8.26 | 4.5 |
| Next year | 4.31 | 13.29 | 6.0 |
| Weighted average score | 4.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -4.94 | 0 | 135.78 | 30.47 | 5.5 |
| Y/Y | 6.17 | 65.43 | 14.22 | -10.82 | 6.0 |
| 3y average | 7.63 | -4.26 | -4.28 | -12.8 | 2.3 |
| 5y average | 8.43 | -9.61 | 0.52 | -7.14 | 2.5 |
| Weighted average score | 4.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 3.57 | 3.57 | 8.0 |
| Payout ratio | 37.16 | 37.16 | 6.0 |
| 5-year dividend growth rate | 5.87 | 5.87 | 7.0 |
| Years of dividend increase | 4.00 | 4.00 | 4.0 |
| Weighted average score | 6.3 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 7.0 |
| Intangible assets | Medium | 6.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Narrow | 3.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 5.8 | |
Total debt $78.3B significantly exceeds cash reserves ($9.6B), raising financial stability concerns
Total current liabilities $86.4B surpass Total current assets $74.8B, signaling liquidity issues
Debt-to-equity ratio (1.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (6x) indicates the company easily manages its debt payments
The company generates positive free cash flow $3.4B, supporting its financial health